Cargando…

Cannabis Extract Effects on Metabolic Parameters and Gut Microbiota Composition in a Mice Model of NAFLD and Obesity

Nonalcoholic fatty liver disease (NAFLD) is a major cause of chronic liver abnormalities and has been linked with metabolic syndrome hallmarks. Unfortunately, current treatments are limited. This work aimed to elucidate the effects of three cannabis extracts on metabolic alteration and gut microbiot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zandani, Gil, Anavi-Cohen, Sarit, Assa-Glazer, Tal, Gorelick, Jonathan, Nyska, Abraham, Sela, Noa, Bernstein, Nirit, Madar, Zecharia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251106/ https://www.ncbi.nlm.nih.gov/pubmed/35795290 http://dx.doi.org/10.1155/2022/7964018

Ejemplares similares

Effects of high oleic acid peanuts on mice’s liver and adipose tissue metabolic parameters and gut microbiota composition
por: Anavi-Cohen, Sarit, et al.
Publicado: (2023)

Broccoli Florets Supplementation Improves Insulin Sensitivity and Alters Gut Microbiome Population—A Steatosis Mice Model Induced by High-Fat Diet
por: Zandani, Gil, et al.
Publicado: (2021)

THC and CBD affect metabolic syndrome parameters including microbiome in mice fed high fat-cholesterol diet
por: Gorelick, Jonathan, et al.
Publicado: (2022)

Chiliadenus iphionoides Reduces Body Weight and Improves Parameters Related to Hepatic Lipid and Glucose Metabolism in a High-Fat-Diet-Induced Mice Model of NAFLD
por: Zandani, Gil, et al.
Publicado: (2022)

Metabolic and Microbiome Alterations Following the Enrichment of a High-Fat Diet With High Oleic Acid Peanuts Versus the Traditional Peanuts Cultivar in Mice
por: Anavi-Cohen, Sarit, et al.
Publicado: (2022)

High oleic peanuts improve parameters leading to fatty liver development and change the microbiota in mice intestine
por: Bimro, Elise Taieb, et al.
Publicado: (2020)

Non-alcoholic fatty liver disease, to struggle with the strangle: Oxygen availability in fatty livers
por: Anavi, Sarit, et al.
Publicado: (2017)

Fatty acids-stress attenuates gluconeogenesis induction and glucose production in primary hepatocytes
por: Budick-Harmelin, Noga, et al.
Publicado: (2012)

Impact of N, P, K, and Humic Acid Supplementation on the Chemical Profile of Medical Cannabis (Cannabis sativa L)
por: Bernstein, Nirit, et al.
Publicado: (2019)

Response of Medical Cannabis (Cannabis sativa L.) to Nitrogen Supply Under Long Photoperiod
por: Saloner, Avia, et al.
Publicado: (2020)

Gut Microbiota and Lifestyle Interventions in NAFLD
por: Houghton, David, et al.
Publicado: (2016)

Response of Medical Cannabis (Cannabis sativa L.) Genotypes to K Supply Under Long Photoperiod
por: Saloner, Avia, et al.
Publicado: (2019)

Response of Medical Cannabis to Magnesium (Mg) Supply at the Vegetative Growth Phase
por: Morad, Dalit, et al.
Publicado: (2023)

Gut Microbiota: Association with NAFLD and Metabolic Disturbances
por: Lau, E., et al.
Publicado: (2015)

Advances in the Involvement of Gut Microbiota in Pathophysiology of NAFLD
por: Jiang, Xiaofan, et al.
Publicado: (2020)

The Highs and Lows of P Supply in Medical Cannabis: Effects on Cannabinoids, the Ionome, and Morpho-Physiology
por: Shiponi, Sivan, et al.
Publicado: (2021)

Shape Matters: Plant Architecture Affects Chemical Uniformity in Large-Size Medical Cannabis Plants
por: Danziger, Nadav, et al.
Publicado: (2021)

Architecture and Florogenesis in Female Cannabis sativa Plants
por: Spitzer-Rimon, Ben, et al.
Publicado: (2019)

Gut Microbiota Metabolites in NAFLD Pathogenesis and Therapeutic Implications
por: Chen, Jiezhong, et al.
Publicado: (2020)

Nutritional Approach Targeting Gut Microbiota in NAFLD—To Date
por: Moszak, Małgorzata, et al.
Publicado: (2021)

Gut Microbiota and NAFLD: Pathogenetic Mechanisms, Microbiota Signatures, and Therapeutic Interventions
por: Hrncir, Tomas, et al.
Publicado: (2021)

Nitrogen Source Matters: High NH(4)/NO(3) Ratio Reduces Cannabinoids, Terpenoids, and Yield in Medical Cannabis
por: Saloner, Avia, et al.
Publicado: (2022)

Ecdysteroid Content and Therapeutic Activity in Elicited Spinach Accessions
por: Gorelick, Jonathan, et al.
Publicado: (2020)

Too Dense or Not Too Dense: Higher Planting Density Reduces Cannabinoid Uniformity but Increases Yield/Area in Drug-Type Medical Cannabis
por: Danziger, Nadav, et al.
Publicado: (2022)

CONSORT-Characteristics and metabolic phenotype of gut microbiota in NAFLD patients
por: Ge, Haize, et al.
Publicado: (2022)

“The Two Sides of the Same Coin”—Medical Cannabis, Cannabinoids and Immunity: Pros and Cons Explained
por: Khoury, Mona, et al.
Publicado: (2022)

The gut microbiota in infants of obese mothers increases inflammation and susceptibility to NAFLD
por: Soderborg, Taylor K., et al.
Publicado: (2018)

The Positive Effects of Grifola frondosa Heteropolysaccharide on NAFLD and Regulation of the Gut Microbiota
por: Li, Xin, et al.
Publicado: (2019)

Chlorogenic Acid Improves NAFLD by Regulating gut Microbiota and GLP-1
por: Shi, Ameng, et al.
Publicado: (2021)

The identification of metabolites from gut microbiota in NAFLD via network pharmacology
por: Oh, Ki-Kwang, et al.
Publicado: (2023)

Cannabis and Endometriosis: The Roles of the Gut Microbiota and the Endocannabinoid System
por: Farooqi, Toobah, et al.
Publicado: (2023)

Current Research on the Pathogenesis of NAFLD/NASH and the Gut–Liver Axis: Gut Microbiota, Dysbiosis, and Leaky-Gut Syndrome
por: Kobayashi, Takashi, et al.
Publicado: (2022)

Thioredoxin/Glutaredoxin Systems and Gut Microbiota in NAFLD: Interplay, Mechanism, and Therapeutical Potential
por: Zhu, Minghui, et al.
Publicado: (2023)

The Role of Gut–Liver Axis in Gut Microbiome Dysbiosis Associated NAFLD and NAFLD-HCC
por: Song, Qian, et al.
Publicado: (2022)

Lettuce Chlorosis Virus Disease: A New Threat to Cannabis Production
por: Hadad, Lior, et al.
Publicado: (2019)

Salinity Stress Does Not Affect Root Uptake, Dissemination and Persistence of Salmonella in Sweet-basil (Ocimum basilicum)
por: Bernstein, Nirit, et al.
Publicado: (2017)

Meta-Omic Platforms to Assist in the Understanding of NAFLD Gut Microbiota Alterations: Tools and Applications
por: Del Chierico, Federica, et al.
Publicado: (2014)

Author Correction: The gut microbiota in infants of obese mothers increases inflammation and susceptibility to NAFLD
por: Soderborg, Taylor K., et al.
Publicado: (2019)

Effect of Sheng-Jiang Powder on Gut Microbiota in High-Fat Diet-Induced NAFLD
por: Li, Juan, et al.
Publicado: (2020)

Akkermansia muciniphila and Bifidobacterium bifidum Prevent NAFLD by Regulating FXR Expression and Gut Microbiota
por: Nian, Fulin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lru2dde7ocvd5bactr7o2qkbgh